-
1
-
-
0025010979
-
The GTPase superfamily: A conserved switch for diverse cell functions
-
Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature 1990; 348: 125-132.
-
(1990)
Nature
, vol.348
, pp. 125-132
-
-
Bourne, H.R.1
Sanders, D.A.2
McCormick, F.3
-
2
-
-
0037264633
-
Targeting RAS signalling pathways in cancer therapy
-
Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 2003; 3: 11-22
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 11-22
-
-
Downward, J.1
-
3
-
-
84879415832
-
-
COSMIC database
-
COSMIC database http://www.sanger.ac.uk/genetics/CGP/cosmic/.
-
-
-
-
4
-
-
42949142189
-
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
-
Schlenk RF, Dohner K, Krauter J, Frohling S, Corbacioglu A, Bullinger L et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1909-1918.
-
(2008)
N Engl J Med
, vol.358
, pp. 1909-1918
-
-
Schlenk, R.F.1
Dohner, K.2
Krauter, J.3
Frohling, S.4
Corbacioglu, A.5
Bullinger, L.6
-
5
-
-
77956237515
-
Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1
-
Kohlmann A, Grossmann V, Klein HU, Schindela S, Weiss T, Kazak B et al. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J Clin Oncol 2010; 28: 3858-3865.
-
(2010)
J Clin Oncol
, vol.28
, pp. 3858-3865
-
-
Kohlmann, A.1
Grossmann, V.2
Klein, H.U.3
Schindela, S.4
Weiss, T.5
Kazak, B.6
-
6
-
-
43449083229
-
Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia
-
Koike K, Matsuda K. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia. Br J Haematol 2008; 141: 567-575.
-
(2008)
Br J Haematol
, vol.141
, pp. 567-575
-
-
Koike, K.1
Matsuda, K.2
-
7
-
-
0034284027
-
Targeting the Ras signaling pathway: A rational, mechanism-based treatment for hematologic malignancies?
-
Reuter CW, Morgan MA, Bergmann L. Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies? Blood 2000; 96: 1655-1669.
-
(2000)
Blood
, vol.96
, pp. 1655-1669
-
-
Reuter, C.W.1
Morgan, M.A.2
Bergmann, L.3
-
8
-
-
0029966854
-
The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomo-nocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways
-
Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomo-nocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways. Proc Natl Acad Sci USA 1996; 93: 14845-14850.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 14845-14850
-
-
Carroll, M.1
Tomasson, M.H.2
Barker, G.F.3
Golub, T.R.4
Gilliland, D.G.5
-
9
-
-
70349249988
-
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia
-
Loh ML, Sakai DS, Flotho C, Kang M, Fliegauf M, Archambeault S et al. Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood 2009; 114: 1859-1863.
-
(2009)
Blood
, vol.114
, pp. 1859-1863
-
-
Loh, M.L.1
Sakai, D.S.2
Flotho, C.3
Kang, M.4
Fliegauf, M.5
Archambeault, S.6
-
10
-
-
84984935016
-
Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
-
Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ et al. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet 2010; 42: 794-800.
-
(2010)
Nat Genet
, vol.42
, pp. 794-800
-
-
Niemeyer, C.M.1
Kang, M.W.2
Shin, D.H.3
Furlan, I.4
Erlacher, M.5
Bunin, N.J.6
-
11
-
-
76549092856
-
Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1
-
Steinemann D, Arning L, Praulich I, Stuhrmann M, Hasle H, Stary J et al. Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1. Haematologica 2010; 95: 320-323.
-
(2010)
Haematologica
, vol.95
, pp. 320-323
-
-
Steinemann, D.1
Arning, L.2
Praulich, I.3
Stuhrmann, M.4
Hasle, H.5
Stary, J.6
-
12
-
-
0030843626
-
Juvenile myelomonocytic leukemia
-
Arico M, Biondi A, Pui CH. Juvenile myelomonocytic leukemia. Blood 1997; 90: 479-488.
-
(1997)
Blood
, vol.90
, pp. 479-488
-
-
Arico, M.1
Biondi, A.2
Pui, C.H.3
-
13
-
-
0041526704
-
Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia
-
Morgan MA, Ganser A, Reuter CW. Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia. Leukemia 2003; 17: 1482-1498.
-
(2003)
Leukemia
, vol.17
, pp. 1482-1498
-
-
Morgan, M.A.1
Ganser, A.2
Reuter, C.W.3
-
14
-
-
0026555721
-
Retroviral infection accelerates T lymphoma-genesis in e mu-N-ras transgenic mice by activating c-myc or N-myc
-
Haupt Y, Harris AW, Adams JM. Retroviral infection accelerates T lymphoma-genesis in E mu-N-ras transgenic mice by activating c-myc or N-myc. Oncogene 1992; 7: 981-986.
-
(1992)
Oncogene
, vol.7
, pp. 981-986
-
-
Haupt, Y.1
Harris, A.W.2
Adams, J.M.3
-
15
-
-
78650651360
-
Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia
-
Wang J, Liu Y, Li Z, Du J, Ryu MJ, Taylor PR et al. Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia. Blood 2010; 116: 5991-6002.
-
(2010)
Blood
, vol.116
, pp. 5991-6002
-
-
Wang, J.1
Liu, Y.2
Li, Z.3
Du, J.4
Ryu, M.J.5
Taylor, P.R.6
-
16
-
-
0033559734
-
Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice
-
MacKenzie KL, Dolnikov A, Millington M, Shounan Y, Symonds G. Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice. Blood 1999; 93: 2043-2056.
-
(1999)
Blood
, vol.93
, pp. 2043-2056
-
-
MacKenzie, K.L.1
Dolnikov, A.2
Millington, M.3
Shounan, Y.4
Symonds, G.5
-
17
-
-
33749320394
-
Oncogenic NRAS rapidly and efficiently induces CMML-and AML-like diseases in mice
-
Parikh C, Subrahmanyam R, Ren R. Oncogenic NRAS rapidly and efficiently induces CMML-and AML-like diseases in mice. Blood 2006; 108: 2349-2357.
-
(2006)
Blood
, vol.108
, pp. 2349-2357
-
-
Parikh, C.1
Subrahmanyam, R.2
Ren, R.3
-
18
-
-
23044459131
-
Repressible transgenic model of NRAS oncogene-driven mast cell disease in the mouse
-
Wiesner SM, Jones JM, Hasz DE, Largaespada DA. Repressible transgenic model of NRAS oncogene-driven mast cell disease in the mouse. Blood 2005; 106: 1054-1062.
-
(2005)
Blood
, vol.106
, pp. 1054-1062
-
-
Wiesner, S.M.1
Jones, J.M.2
Hasz, D.E.3
Largaespada, D.A.4
-
19
-
-
0025234915
-
Murine macrophage precursor characterization. II. Monoclonal antibodies against macrophage precursor antigens
-
Leenen PJ, Melis M, Slieker WA, Van Ewijk W. Murine macrophage precursor characterization. II. Monoclonal antibodies against macrophage precursor antigens. Eur J Immunol 1990; 20: 27-34.
-
(1990)
Eur J Immunol
, vol.20
, pp. 27-34
-
-
Leenen, P.J.1
Melis, M.2
Slieker, W.A.3
Van Ewijk, W.4
-
20
-
-
77954502166
-
The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice
-
Hao X, Fredrickson TN, Chattopadhyay SK, Han W, Qi CF, Wang Z et al. The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice. Vet Pathol 2010; 47: 434-445.
-
(2010)
Vet Pathol
, vol.47
, pp. 434-445
-
-
Hao, X.1
Fredrickson, T.N.2
Chattopadhyay, S.K.3
Han, W.4
Qi, C.F.5
Wang, Z.6
-
21
-
-
77349093317
-
Heterogeneity in a mouse model of histiocytosis: Transformation of Langerin + dendritic cells, macrophages, and precursors
-
Leenen PJ, Bechan GI, Melis M, den Broeder BJ, Lohler J, Egeler RM. Heterogeneity in a mouse model of histiocytosis: transformation of Langerin + dendritic cells, macrophages, and precursors. J Leukoc Biol 2010; 87: 949-958.
-
(2010)
J Leukoc Biol
, vol.87
, pp. 949-958
-
-
Leenen, P.J.1
Bechan, G.I.2
Melis, M.3
Den Broeder, B.J.4
Lohler, J.5
Egeler, R.M.6
-
22
-
-
0035985576
-
Tumours of histiocytes and accessory dendritic cells: An immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases
-
Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002; 41: 1-29.
-
(2002)
Histopathology
, vol.41
, pp. 1-29
-
-
Pileri, S.A.1
Grogan, T.M.2
Harris, N.L.3
Banks, P.4
Campo, E.5
Chan, J.K.6
-
23
-
-
0030944985
-
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
-
Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88: 593-602.
-
(1997)
Cell
, vol.88
, pp. 593-602
-
-
Serrano, M.1
Lin, A.W.2
McCurrach, M.E.3
Beach, D.4
Lowe, S.W.5
-
24
-
-
4644266046
-
Ha-Ras(G12V) induces senescence in primary and immortalized human esopha-geal keratinocytes with p53 dysfunction
-
Takaoka M, Harada H, Deramaudt TB, Oyama K, Andl CD, Johnstone CN et al. Ha-Ras(G12V) induces senescence in primary and immortalized human esopha-geal keratinocytes with p53 dysfunction. Oncogene 2004; 23: 6760-6768.
-
(2004)
Oncogene
, vol.23
, pp. 6760-6768
-
-
Takaoka, M.1
Harada, H.2
Deramaudt, T.B.3
Oyama, K.4
Andl, C.D.5
Johnstone, C.N.6
-
25
-
-
52949129499
-
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates
-
Kotecha N, Flores NJ, Irish JM, Simonds EF, Sakai DS, Archambeault S et al. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell 2008; 14: 335-343.
-
(2008)
Cancer Cell
, vol.14
, pp. 335-343
-
-
Kotecha, N.1
Flores, N.J.2
Irish, J.M.3
Simonds, E.F.4
Sakai, D.S.5
Archambeault, S.6
-
26
-
-
42949122111
-
High EVI1 levels predict adverse outcome in acute myeloid leukemia: Prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated
-
Lugthart S, van Drunen E, van Norden Y, van Hoven A, Erpelinck CA, Valk PJ et al. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood 2008; 111: 4329-4337.
-
(2008)
Blood
, vol.111
, pp. 4329-4337
-
-
Lugthart, S.1
Van Drunen, E.2
Van Norden, Y.3
Van Hoven, A.4
Erpelinck, C.A.5
Valk, P.J.6
-
27
-
-
0345863840
-
RTCGD: Retroviral tagged cancer gene database
-
Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 2004; 32: D523-D527.
-
(2004)
Nucleic Acids Res
, vol.32
-
-
Akagi, K.1
Suzuki, T.2
Stephens, R.M.3
Jenkins, N.A.4
Copeland, N.G.5
-
28
-
-
27944449787
-
Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells
-
Du Y, Jenkins NA, Copeland NG. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 2005; 106: 3932-3939.
-
(2005)
Blood
, vol.106
, pp. 3932-3939
-
-
Du, Y.1
Jenkins, N.A.2
Copeland, N.G.3
-
29
-
-
70449127230
-
Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors
-
Modlich U, Navarro S, Zychlinski D, Maetzig T, Knoess S, Brugman MH et al. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 2009; 17: 1919-1928.
-
(2009)
Mol Ther
, vol.17
, pp. 1919-1928
-
-
Modlich, U.1
Navarro, S.2
Zychlinski, D.3
Maetzig, T.4
Knoess, S.5
Brugman, M.H.6
-
30
-
-
79960261778
-
EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells
-
De Weer A, Van der Meulen J, Rondou P, Taghon T, Konrad TA, De Preter K et al. EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells. Br J Haematol 2011; 154: 337-348.
-
(2011)
Br J Haematol
, vol.154
, pp. 337-348
-
-
De Weer, A.1
Van Der Meulen, J.2
Rondou, P.3
Taghon, T.4
Konrad, T.A.5
De Preter, K.6
-
31
-
-
80053252121
-
Acetylation of the proto-oncogene EVI1 abrogates Bcl-xL promoter binding and induces apoptosis
-
Pradhan AK, Mohapatra AD, Nayak KB, Chakraborty S. Acetylation of the proto-oncogene EVI1 abrogates Bcl-xL promoter binding and induces apoptosis. PLoS One 2011; 6: e25370.
-
(2011)
PLoS One
, vol.6
-
-
Pradhan, A.K.1
Mohapatra, A.D.2
Nayak, K.B.3
Chakraborty, S.4
-
32
-
-
33750624015
-
Cell culture assays reveal the importance of retroviral vector design for insertional genotoxicity
-
Modlich U, Bohne J, Schmidt M, von Kalle C, Knob S, Schambach A et al. Cell culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood 2006; 108: 2545-2553.
-
(2006)
Blood
, vol.108
, pp. 2545-2553
-
-
Modlich, U.1
Bohne, J.2
Schmidt, M.3
Von Kalle, C.4
Knob, S.5
Schambach, A.6
-
34
-
-
0036682167
-
The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene
-
Diaz R, Ahn D, Lopez-Barcons L, Malumbres M, Perez de Castro I, Lue J et al. The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res 2002; 62: 4514-4518.
-
(2002)
Cancer Res
, vol.62
, pp. 4514-4518
-
-
Diaz, R.1
Ahn, D.2
Lopez-Barcons, L.3
Malumbres, M.4
Perez De Castro, I.5
Lue, J.6
-
35
-
-
1942436234
-
Complex effects of Ras proto-oncogenes in tumorigenesis
-
Diaz R, Lopez-Barcons L, Ahn D, Garcia-Espana A, Yoon A, Matthews J et al. Complex effects of Ras proto-oncogenes in tumorigenesis. Carcinogenesis 2004; 25: 535-539.
-
(2004)
Carcinogenesis
, vol.25
, pp. 535-539
-
-
Diaz, R.1
Lopez-Barcons, L.2
Ahn, D.3
Garcia-Espana, A.4
Yoon, A.5
Matthews, J.6
-
36
-
-
11944271042
-
Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice
-
Mangues R, Seidman I, Gordon JW, Pellicer A. Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice. Oncogene 1992; 7: 2073-2076.
-
(1992)
Oncogene
, vol.7
, pp. 2073-2076
-
-
Mangues, R.1
Seidman, I.2
Gordon, J.W.3
Pellicer, A.4
-
37
-
-
0028618377
-
An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis
-
Mangues R, Kahn JM, Seidman I, Pellicer A. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis. Cancer Res 1994; 54: 6395-6401.
-
(1994)
Cancer Res
, vol.54
, pp. 6395-6401
-
-
Mangues, R.1
Kahn, J.M.2
Seidman, I.3
Pellicer, A.4
-
38
-
-
0029774270
-
Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumor-igenesis
-
Mangues R, Symmans WF, Lu S, Schwartz S, Pellicer A. Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumor-igenesis. Oncogene 1996; 13: 1053-1063.
-
(1996)
Oncogene
, vol.13
, pp. 1053-1063
-
-
Mangues, R.1
Symmans, W.F.2
Lu, S.3
Schwartz, S.4
Pellicer, A.5
-
39
-
-
42249090881
-
Targeting Ras in myeloid leukemias
-
Braun BS, Shannon K. Targeting Ras in myeloid leukemias. Clin Cancer Res 2008; 14: 2249-2252.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 2249-2252
-
-
Braun, B.S.1
Shannon, K.2
-
40
-
-
76249095169
-
Development of monocytes, macrophages, and dendritic cells
-
Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010; 327: 656-661.
-
(2010)
Science
, vol.327
, pp. 656-661
-
-
Geissmann, F.1
Manz, M.G.2
Jung, S.3
Sieweke, M.H.4
Merad, M.5
Ley, K.6
-
41
-
-
0027970795
-
Histiocytes and histiocytosis
-
Cline MJ. Histiocytes and histiocytosis. Blood 1994; 84: 2840-2853.
-
(1994)
Blood
, vol.84
, pp. 2840-2853
-
-
Cline, M.J.1
-
42
-
-
0023640053
-
Murine retrovirus-induced malignant histiocytosis, an experimental model for the disease in humans
-
Lohler J, Franz T, Fusco A, Pragnell I, Ostertag W. Murine retrovirus-induced malignant histiocytosis, an experimental model for the disease in humans. Leukemia 1987; 1: 58-68.
-
(1987)
Leukemia
, vol.1
, pp. 58-68
-
-
Lohler, J.1
Franz, T.2
Fusco, A.3
Pragnell, I.4
Ostertag, W.5
-
43
-
-
23244461708
-
Oncogene-induced senescence as an initial barrier in lymphoma development
-
Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436: 660-665.
-
(2005)
Nature
, vol.436
, pp. 660-665
-
-
Braig, M.1
Lee, S.2
Loddenkemper, C.3
Rudolph, C.4
Peters, A.H.5
Schlegelberger, B.6
-
44
-
-
0028883813
-
Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells
-
Baum C, Hegewisch-Becker S, Eckert HG, Stocking C, Ostertag W. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol 1995; 69: 7541-7547.
-
(1995)
J Virol
, vol.69
, pp. 7541-7547
-
-
Baum, C.1
Hegewisch-Becker, S.2
Eckert, H.G.3
Stocking, C.4
Ostertag, W.5
-
45
-
-
0036133070
-
In vivo analysis of retroviral enhancer mutations in hematopoietic cells: SP1/EGR1 and ETS/GATA motifs contribute to long terminal repeat specificity
-
Wahlers A, Zipfel PF, Schwieger M, Ostertag W, Baum C. In vivo analysis of retroviral enhancer mutations in hematopoietic cells: SP1/EGR1 and ETS/GATA motifs contribute to long terminal repeat specificity. J Virol 2002; 76: 303-312.
-
(2002)
J Virol
, vol.76
, pp. 303-312
-
-
Wahlers, A.1
Zipfel, P.F.2
Schwieger, M.3
Ostertag, W.4
Baum, C.5
-
46
-
-
0036764776
-
Upstream conserved sequences of mouse leukemia viruses are important for high trans-gene expression in lymphoid and hematopoietic cells
-
Wahlers A, Kustikova O, Zipfel PF, Itoh K, Koester M, Heberlein C et al. Upstream conserved sequences of mouse leukemia viruses are important for high trans-gene expression in lymphoid and hematopoietic cells. Mol Ther 2002; 6: 313-320.
-
(2002)
Mol Ther
, vol.6
, pp. 313-320
-
-
Wahlers, A.1
Kustikova, O.2
Zipfel, P.F.3
Itoh, K.4
Koester, M.5
Heberlein, C.6
-
47
-
-
0036720398
-
The roles of FLT3 in hematopoiesis and leukemia
-
Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood 2002; 100: 1532-1542.
-
(2002)
Blood
, vol.100
, pp. 1532-1542
-
-
Gilliland, D.G.1
Griffin, J.D.2
-
48
-
-
79955814184
-
The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: A study in 39 cases of MDS or AML
-
Haferlach C, Bacher U, Haferlach T, Dicker F, Alpermann T, Kern W et al. The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML. Leukemia 2011; 25: 874-877.
-
(2011)
Leukemia
, vol.25
, pp. 874-877
-
-
Haferlach, C.1
Bacher, U.2
Haferlach, T.3
Dicker, F.4
Alpermann, T.5
Kern, W.6
-
49
-
-
33646575624
-
Implications of NRAS mutations in AML: A study of 2502 patients
-
Bacher U, Haferlach T, Schoch C, Kern W, Schnittger S. Implications of NRAS mutations in AML: a study of 2502 patients. Blood 2006; 107: 3847-3853.
-
(2006)
Blood
, vol.107
, pp. 3847-3853
-
-
Bacher, U.1
Haferlach, T.2
Schoch, C.3
Kern, W.4
Schnittger, S.5
-
50
-
-
77956247735
-
Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia
-
Lugthart S, Groschel S, Beverloo HB, Kayser S, Valk PJ, van Zelderen-Bhola SL et al. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. J Clin Oncol 2010; 28: 3890-3898.
-
(2010)
J Clin Oncol
, vol.28
, pp. 3890-3898
-
-
Lugthart, S.1
Groschel, S.2
Beverloo, H.B.3
Kayser, S.4
Valk, P.J.5
Van Zelderen-Bhola, S.L.6
-
51
-
-
36849080028
-
Over-expression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice
-
Shing DC, Trubia M, Marchesi F, Radaelli E, Belloni E, Tapinassi C et al. Over-expression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice. J Clin Invest 2007; 117: 3696-3707.
-
(2007)
J Clin Invest
, vol.117
, pp. 3696-3707
-
-
Shing, D.C.1
Trubia, M.2
Marchesi, F.3
Radaelli, E.4
Belloni, E.5
Tapinassi, C.6
-
52
-
-
79951472496
-
Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus
-
Li Q, Haigis KM, McDaniel A, Harding-Theobald E, Kogan SC, Akagi K et al. Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus. Blood 2011; 117: 2022-2032.
-
(2011)
Blood
, vol.117
, pp. 2022-2032
-
-
Li, Q.1
Haigis, K.M.2
McDaniel, A.3
Harding-Theobald, E.4
Kogan, S.C.5
Akagi, K.6
-
53
-
-
85047694750
-
EVI1 induces myelodys-plastic syndrome in mice
-
Buonamici S, Li D, Chi Y, Zhao R, Wang X, Brace L et al. EVI1 induces myelodys-plastic syndrome in mice. J Clin Invest 2004; 114: 713-719.
-
(2004)
J Clin Invest
, vol.114
, pp. 713-719
-
-
Buonamici, S.1
Li, D.2
Chi, Y.3
Zhao, R.4
Wang, X.5
Brace, L.6
-
54
-
-
34247391073
-
Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis
-
Jin G, Yamazaki Y, Takuwa M, Takahara T, Kaneko K, Kuwata T et al. Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis. Blood 2007; 109: 3998-4005.
-
(2007)
Blood
, vol.109
, pp. 3998-4005
-
-
Jin, G.1
Yamazaki, Y.2
Takuwa, M.3
Takahara, T.4
Kaneko, K.5
Kuwata, T.6
-
55
-
-
0842329808
-
Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice
-
Cuenco GM, Ren R. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice. Oncogene 2004; 23: 569-579.
-
(2004)
Oncogene
, vol.23
, pp. 569-579
-
-
Cuenco, G.M.1
Ren, R.2
-
56
-
-
21044448037
-
Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking
-
Kustikova O, Fehse B, Modlich U, Yang M, Dullmann J, Kamino K et al. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 2005; 308: 1171-1174.
-
(2005)
Science
, vol.308
, pp. 1171-1174
-
-
Kustikova, O.1
Fehse, B.2
Modlich, U.3
Yang, M.4
Dullmann, J.5
Kamino, K.6
-
57
-
-
49449084991
-
Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16
-
Modlich U, Schambach A, Brugman MH, Wicke DC, Knoess S, Li Z et al. Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16. Leukemia 2008; 22: 1519-1528.
-
(2008)
Leukemia
, vol.22
, pp. 1519-1528
-
-
Modlich, U.1
Schambach, A.2
Brugman, M.H.3
Wicke, D.C.4
Knoess, S.5
Li, Z.6
-
58
-
-
25144490586
-
Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells
-
Calmels B, Ferguson C, Laukkanen MO, Adler R, Faulhaber M, Kim HJ et al. Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Blood 2005; 106: 2530-2533.
-
(2005)
Blood
, vol.106
, pp. 2530-2533
-
-
Calmels, B.1
Ferguson, C.2
Laukkanen, M.O.3
Adler, R.4
Faulhaber, M.5
Kim, H.J.6
-
60
-
-
77957988939
-
EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2
-
Gomez-Benito M, Conchillo A, Garcia MA, Vazquez I, Maicas M, Vicente C et al. EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2. Br J Cancer 103: 1292-1296.
-
Br J Cancer
, vol.103
, pp. 1292-1296
-
-
Gomez-Benito, M.1
Conchillo, A.2
Garcia, M.A.3
Vazquez, I.4
Maicas, M.5
Vicente, C.6
-
61
-
-
80053629212
-
Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia
-
Vazquez I, Maicas M, Cervera J, Agirre X, Marin-Bejar O, Marcotegui N et al. Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia. Haematologica 2011; 96: 1448-1456.
-
(2011)
Haematologica
, vol.96
, pp. 1448-1456
-
-
Vazquez, I.1
Maicas, M.2
Cervera, J.3
Agirre, X.4
Marin-Bejar, O.5
Marcotegui, N.6
-
62
-
-
70349640956
-
Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes
-
Konrad TA, Karger A, Hackl H, Schwarzinger I, Herbacek I, Wieser R. Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes. J Leukoc Biol 2009; 86: 813-822.
-
(2009)
J Leukoc Biol
, vol.86
, pp. 813-822
-
-
Konrad, T.A.1
Karger, A.2
Hackl, H.3
Schwarzinger, I.4
Herbacek, I.5
Wieser, R.6
-
63
-
-
37549065049
-
BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia
-
Omidvar N, Kogan S, Beurlet S, le Pogam C, Janin A, West R et al. BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia. Cancer Res 2007; 67: 11657-11667.
-
(2007)
Cancer Res
, vol.67
, pp. 11657-11667
-
-
Omidvar, N.1
Kogan, S.2
Beurlet, S.3
Le Pogam, C.4
Janin, A.5
West, R.6
-
64
-
-
33750023988
-
Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors
-
Schambach A, Mueller D, Galla M, Verstegen MM, Wagemaker G, Loew R et al. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther 2006; 13: 1524-1533.
-
(2006)
Gene Ther
, vol.13
, pp. 1524-1533
-
-
Schambach, A.1
Mueller, D.2
Galla, M.3
Verstegen, M.M.4
Wagemaker, G.5
Loew, R.6
-
65
-
-
0032520260
-
Carboxyl-truncated STAT5beta is generated by a nucleus-associated serine protease in early hematopoietic rogenitors
-
Meyer J, Jucker M, Ostertag W, Stocking C. Carboxyl-truncated STAT5beta is generated by a nucleus-associated serine protease in early hematopoietic rogenitors. Blood 1998; 91: 1901-1908.
-
(1998)
Blood
, vol.91
, pp. 1901-1908
-
-
Meyer, J.1
Jucker, M.2
Ostertag, W.3
Stocking, C.4
-
66
-
-
0034915569
-
Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples
-
Schmidt M, Hoffmann G, Wissler M, Lemke N, Mussig A, Glimm H et al. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum Gene Ther 2001; 12: 743-749.
-
(2001)
Hum Gene Ther
, vol.12
, pp. 743-749
-
-
Schmidt, M.1
Hoffmann, G.2
Wissler, M.3
Lemke, N.4
Mussig, A.5
Glimm, H.6
-
67
-
-
60749091879
-
Retroviral insertion site analysis in dominant haematopoietic clones
-
Kustikova OS, Modlich U, Fehse B. Retroviral insertion site analysis in dominant haematopoietic clones. Methods Mol Biol 2009; 506: 373-390.
-
(2009)
Methods Mol Biol
, vol.506
, pp. 373-390
-
-
Kustikova, O.S.1
Modlich, U.2
Fehse, B.3
|